T-DM1 Boosts Survival in HER2-Positive Breast Cancer
TOPLINE:Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth...
TOPLINE:Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth...
TOPLINE:The increase in incidence of pancreatic cancer among young Americans is largely due to improved detection of early-stage endocrine cancer,...